Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

NCT00761319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

705

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
DRUG: Latanoprost ophthalmic solution 0.005% (XALATAN®)

Sponsor

Alcon Research